Apeloa Pharmaceutical Co.,Ltd (SZSE: 000739)
Health Care · Pharmaceuticals · CN
CN¥20.72
-8.12% today · +24.4% 1Y
Apeloa Pharmaceutical Co.,Ltd (SZSE: 000739) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.47B and employs 6,787 people.
Over the last twelve months the share price has gained 24.4%, trading between 14.89 and 24.85.
Tweenvest scores Apeloa Pharmaceutical Co.,Ltd across four factors: quality 82/100, value 37/100, growth 17/100, dividend 17/100. Its strongest factor is quality.
000739 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.47B
- Revenue (TTM)
- $1.35B
- P/E
- 28.10
- EPS
- 0.74
- Dividend yield
- 2.30%
- Beta (5Y)
- 0.21
- 52-week high
- CN¥24.85
- 52-week low
- CN¥14.89
- Avg volume (3M)
- —
- Shares outstanding
- 1.13B
- Employees
- 6,787
- Next earnings
- —
About Apeloa Pharmaceutical Co.,Ltd
Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical enterprise, specializing in the discovery, development, production, and global distribution of a diverse range of medicinal products. Its market reach spans China and various international territories. The company strategically focuses its product portfolio on several critical medical fields, including cardiovascular and cerebrovascular health, anti-infective treatments, antiviral therapies, and oncology (cancer treatment), alongside other therapeutic categories. Apeloa's offerings encompass finished pharmaceutical preparations, raw material intermediates (active pharmaceutical ingredients and their precursors), and veterinary medicines. These products are primarily recognized and sold under key brands such as Tianliwei, Beshin, Yosemade, and Jutai, among others. Furthermore, the company extends its expertise to other pharmaceutical businesses by providing contract research, development, and manufacturing (CDMO) services. The corporate headquarters for Apeloa Pharmaceutical Co.,Ltd are located in Dongyang, China.
- ISIN
- CNE000000Q45
- Founded
- 1989
- Listed since
- May 9, 1997
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.